Cart
sales@molnova.com
Alprenolol hydrochloride
CAS No. 13707-88-5
Alprenolol hydrochloride ( —— )
Catalog No. M22090 CAS No. 13707-88-5
Alprenolol hydrochloride is a non-selective blocker of beta, and also is a antagonist of5-HT1A receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 52 | In Stock |
|
| 100MG | 88 | In Stock |
|
| 200MG | 141 | In Stock |
|
| 500MG | 316 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlprenolol hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlprenolol hydrochloride is a non-selective blocker of beta, and also is a antagonist of5-HT1A receptor.
-
DescriptionAlprenolol hydrochloride is a non-selective blocker of beta, and also is a antagonist of5-HT1A receptor.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT1A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13707-88-5
-
Formula Weight285.81
-
Molecular FormulaC15H24ClNO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:95 mg/mL (332.39 mM; Need ultrasonic); H2O:50 mg/mL (174.94 mM; Need ultrasonic)
-
SMILESCl.CC(C)NCC(O)COc1ccccc1CC=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Millan MJ et al. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. J Pharmacol Exp Ther, 1994 Jan, 268(1):337-52.
molnova catalog
related products
-
Ataractan
Azacyclonol, also known as γ-pipradol, is a drug used to diminish hallucinations in psychotic individuals.
-
Ansofaxine hydrochlo...
Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).
-
Elbasvir
Elbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.
